Measles is misery: A brief update for paediatricians

Nichkamol Lertamornkitti1, Philip N Britton2

  • 1Department of Infectious Diseases & Microbiology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

PubMed

Insights

Measles outbreaks are increasing globally due to declining vaccination rates and vaccine hesitancy. Early diagnosis and vaccination are crucial for controlling this contagious disease and preventing serious complications.

Area of Science:

  • * Public Health
  • * Infectious Diseases
  • * Immunology

Background:

  • * Measles, a vaccine-preventable illness, has seen a resurgence globally.
  • * The COVID-19 pandemic disrupted routine immunisation, leading to decreased vaccine coverage and altered patterns of respiratory virus infections.
  • * Rising vaccine hesitancy poses a significant public health challenge, contributing to intensified measles outbreaks.

Purpose of the Study:

  • * To emphasize the importance of understanding measles clinical presentation for timely diagnosis.
  • * To highlight the critical need for reducing measles transmission.
  • * To underscore vaccination as the primary prevention strategy.

Main Methods:

  • * Review of current epidemiological data on measles incidence and outbreaks.
  • * Analysis of factors contributing to vaccine hesitancy and declining immunisation rates.
  • * Examination of the clinical manifestations and potential complications of measles infection.

Main Results:

  • * Measles outbreaks have intensified globally, linked to pandemic-related immunisation disruptions.
  • * Vaccine hesitancy is a major factor exacerbating the re-emergence of measles.
  • * Early recognition of measles symptoms is vital for effective containment.

Conclusions:

  • * Vaccination remains the most effective method for measles prevention and control.
  • * Addressing vaccine hesitancy is essential to restore and maintain high immunisation coverage.
  • * Prompt diagnosis and isolation are key to limiting the spread of this highly contagious disease.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234